Sannabis SAS met with Ministry of Justice and United Nations to discuss hemp and cannabis based medical products.
Bogotá, Colombia, January 30, 2015/– New Colombia Resources, Inc. (OTCQB: NEWC) (“New Colombia or the ‘Company”), a U.S. company with coal and other resource assets in Colombia, is pleased to update shareholders on the progress of their cannabis and mining operations.
New Colombia’s subsidiary, Sannabis SAS, has legally been producing cannabis based medicines on autonomous Indian Nations in Colombia for over two years. Sannabis met with representatives of the United Nations on January 16, 2015 to discuss hemp production and medical cannabis cultivation on indigenous land. Another meeting is scheduled next month to formalize a relationship.
WHITEFISH, MT / January 28, 2015 / GoPro (GPRO) last week announced a partnership with the National Hockey League (NHL) to provide hockey fans never-before-seen perspectives of the game, including the use of cameras worn by players and officials. The company also is in partnership with Vislink to provide real-time, on-athlete video perspectives for live broadcasts. Similarly, since the end of November 2014, the Guitammer Company (GTMM) has been partnering with the San Jose Sharks and Comcast SportsNet California (CSNCA) to broadcast this year’s Sharks home games in ‘4D’, utilizing sensors on the boards to broadcast real-time the feel and bone jarring impacts as the NHL players crash each other into the boards for the viewers at home to experience. These developments constitute a compelling step forward in the broadcast of live sports, and it might be worth looking at where this is headed.
Montreal, Quebec, Canada – January 28, 2015 – Urban Barns Foods Inc. (OTCQB: URBF)(“Urban Barns”), an innovative food producer dedicated to growing consistent, healthy and fresh vegetables year round using its proprietary Cubic Farming™ method, is pleased to provides its shareholders with an update on its research and development (R&D) activities at McGill University.
The Biomass Production Laboratory at McGill University, with support from Urban Barns, is paving the way for research in urban agriculture. Recent innovations with Light Emitting Diodes (LED) as a plant energy source, has brought about this new area of research. LED lighting systems have the capability to control wavelengths emitted. This allows for research on the impact of different spectral wavelength combinations on plant growth and development. Compared to conventional lighting techniques when growing tomatoes, an arrangement of red and blue lights has proven to increase growth, improve morphology, and suppress plant pathogens.
Innovus Pharma Expands its Men’s Health Franchise with the Addition of Exclusive Rights to Androferti® to Support Overall Male Reproductive Health and Sperm Quality for the U.S. and Canadian Market
San Diego, CA – January 28, 2015 — Innovus Pharmaceuticals, Inc. (“Innovus Pharma”) (OTCQB: INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women’s health and vitality, announced today that it entered into an exclusive distribution agreement with Laboratorios Q Pharma (Spain) to distribute and commercialize Androferti®, a patented and clinically proven product to support male reproductive health and sperm quality, in the U.S. and Canada.
Brick Top Productions, Inc. Becomes Carolco Pictures, Inc. as Stock Symbol is Changed to CRCO
BOCA RATON, FL / ACCESSWIRE / January 20, 2015 / Brick Top Productions, Inc. (BTOP)(OTCQB:CRCO), announced that Carolco Pictures, the legendary name behind dozens of film blockbusters such as Rambo, Basic Instinct and Total Recall, is back and making its first appearance in 20 years. Brick Top Productions officially changed its corporate name to Carolco Pictures Inc. and its stock symbol to CRCO.
Diabetes affects nearly 30 million U.S. citizens – or roughly 10% of the population – with about 27% of those cases going undiagnosed, according to the American Diabetes Association. As well, there are approximately 80 million Americans estimated to be pre-diabetic, with 90% being completely unaware of their condition. With about 70,000 deaths in 2010 alone, diabetes is the seventh leading cause of death in the U.S. and that figure could be dramatically understated given the chronic under-diagnosis of the disease.  As well, diabetes and its related complications accounted for $245 billion USD in total medical costs and lost work and wages in the U.S. in 2012.  More than 500 million people worldwide are expected to be affected by diabetes by the year 2030, making it the 7th leading cause of death in the world.  
Early detection and treatment of diabetes can decrease the risk of developing many complications associated with the disease, ranging from nerve damage (seen in half of all diabetics) to high blood pressure (which can lead to cardiac arrest and stroke). Unfortunately, traditional diabetes testing is rarely done during annual physicals because of its invasive nature in requiring a blood draw and analysis, and 40%-60% of patients in the U.S. are noncompliant with blood test orders from their physicians due to cost or fear of needles. 
Sunshine Biopharma Signs Agreement with Lonza to Manufacture Its Lead Anti-Cancer Compound, Adva-27a
MONTREAL, QC–(Marketwired – Nov 19, 2014) – Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, announced today an agreement with Lonza, a leading development and manufacturing company, for the manufacture of its anti-cancer drug, Adva-27a. Lonza’s expertise and experience in small molecule development and manufacturing of active pharmaceutical ingredients, was an ideal fit for Sunshine’s Adva-27a. Lonza’s manufacturing capacity ranges from gram quantities for process validation to kilogram amounts for clinical trials and ton quantities for commercialization. Manufacturing will begin at Lonza’s Nansha, China facility with the remaining key steps to be conducted in Lonza’s high containment cytotoxic facility in Visp, Switzerland.
Ackroo Oversubscribes and Adds the Required Capital to Help Execute Strategic Plans
OTTAWA, ONTARIO – January 20, 2015 – Ackroo Inc. (TSX-V: AKR) (“the Company”), a loyalty and rewards technology and services provider, is pleased to announce that it has closed a private placement for gross proceeds of $1,254,624.75. The Company issued 8,364,165 units to subscribers at a price of $0.15 per unit. Each unit consists of one common share and one share purchase warrant, each whole warrant entitling the holder to acquire one additional common share of the Company at a price of $0.25 per share for a period of 12 months. All securities issued on closing of the Private Placement are subject to a four month and a day hold period. No finder’s fees or commissions were paid in connection with closing of the Private Placement.
Bulova Technologies Group, Inc., announces formation of Bulova Technologies Health Care Products LLC
Tampa, Florida –January 21, 2015 –Bulova Technologies Group, Inc. (OTC: BTGI)(the “Company”) today announced the formation of Bulova Technologies Health Care Products LLC. Bulova Technologies Health Care Products will operate under the newly-created subsidiary, Bulova Technologies Advanced Products LLC, the incubator of new high-tech products intended to be developed and marketed by the Company.
Company Now Shifts to Industry Investors Buyout or Buy In
STATESVILLE, North Carolina (January 22, 2015) – – Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products announced today that The Depository Trust Company (DTC) has determined to lift the Deposit Chill on the company’s stock effective January 21, 2015, and has resumed accepting deposits of Bebida Beverage Company’s common stock for depository and book entry transfer services.
ALTO VENTURES CONFIRMS KIMBERLITE INDICATOR MINERALS ON THE GEFA PROPERTY ADJACENT TO PIKOO, NORTHERN SASKATCHEWAN
Vancouver, B.C., January 22, 2015. Alto Ventures Ltd. (ATV: TSX-V) is pleased to announce recovery of significant Kimberlite Indicator Minerals (KIMs) from till samples on the GEFA Diamond Property, located adjacent to the east of the North Arrow Minerals Inc. Pikoo diamond discovery in Northern Saskatchewan. The KIMs include Cr-rich chromites, Mg-ilmenites, Cr-pyrope garnets and one diamond associated eclogite garnet (Diamond Indicator Mineral “DIM”). Recovery of such an eclogite garnet in till is consistent with an indicator dispersion train having a potentially significant diamondiferous source. Cr-pyrope, eclogite garnet, and Mg-ilmenite KIMs have been particularly useful in this part of Saskatchewan defining the drill targets that resulted in discovery of diamond bearing kimberlite in 2013 on the adjacent Pikoo property.
Success Holding Group International Inc. Files Prospectus’ in Frankfurt and British Columbia, Canada
As of January 20, 2015 SHGT has filed its prospectus with BaFin, the German Securities Commission. Once approved SHGT will be cleared to apply for trading on the Frankfurt Stock Exchange.
As of January 20, 2015 SHGT has also filed a listing statement with the Canadian Securities Exchange and its prospectus with the British Columbia Securities Commission for a listing on the CSE (Canadian Stock Exchange). SHGT is optimistic that it will be approved for trading on the Canadian Stock Exchange within the next couple of weeks.
Watch the Fox KTVU News segment on “4D Sports”
“It’s a great concept. You really feel like you’re a part of the game. You
feel the bumps. Feeling the couch move, actually is pretty cool.” -Sharks Player
Watch the segment
Learn More about Guitammer
WESTERVILLE, OH, January 12, 2015 – The Guitammer Company’s revolutionary 4D
Sports broadcast technology is shaking up how San Jose Sharks fans
experience live hockey. Scott Reiss, KTVU News sports anchor, featured this
ground breaking technology in a piece that aired 1/9/15.
Reiss takes viewers through the technical setup at the SAP Center,
interviews a fan using the technology at home, and examines the future
possibilities for 4D Sports technology.
Premier Biomedical, Inc. (BIEI) announced that they intend to nationally sell an exclusively licensed and patented drug treatment for fibromyalgia. Premier is submitting documents to the Food and Drug Administration to discuss agency requirements for both clinical studies and eventual marketing approval for this patented drug combination. The drug, Feldetrex®, was issued a patent for its unique combination of FDA approved compounds, in October of 2014.
Feldetrex® is designed to treat the symptoms of fibromyalgia, and will compete with several name brand drugs whose combined annual sales exceed $10 billion. Premier Biomedical has obtained exclusive rights to the Feldetrex® patent.
Turbine Truck Engines, Inc. Takes Ownership of the Detonation Cycle Gas Turbine Engine (DCGT) and Gas-to-Liquid (GTL).
Turbine Truck Engines, Inc. (“TTE”) (OTCBB:TTEG, OTCQB:TTEG) announces that all conditions, terms and guarantees of escrow were satisfied allowing Turbine Truck Engines, Inc. (the “Company” or “TTE”) to close, effective November 14, 2014, both the Asset Purchase Agreement and the Technology Sale/Transfer/Assignment for all Intellectual Property (IP) Agreement (the “Agreements”) to obtain ownership, and all rights, title, interest, patents, trademarks, and inventor notes for both the Detonation Cycle Gas Turbine Engine (DCGT) and Gas-to-Liquid (GTL) technologies.
Property appraised at approximately $2.4 million is currently leased to licensed Medical Marijuana Dispensary
Medican Enterprises Inc. (MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announced that it has entered into a purchase agreement to acquire a 7,200 square foot retail and commercial property in Phoenix, Arizona.
The property is currently leased through August 2018 to an Arizona state licensed medical marijuana dispensary. Per the purchase agreement, the lease agreement will be assigned to Medican. The rental amount of the current lease is in excess of $200,000 annually, triple net. The lease provides for two five-year tenant renewal options. The lease rate increases at 3 percent per year or CPI, whichever is greater.
Taipei, Taiwan– January 15, 2015 CNA News: Success Holding Group International Inc. (SHGT OTC: QB) has filed its Quarterly Report on Form 10-Q together with financial statements for the nine-month period ended November 30, 2014 with the United States Securities and Exchange Commission.
At November 30, 2014, SHGT earned gross revenue of $12,250,000. After cost of sales of $7,360,000 and operating expenses of $1,853,094, SHGT recorded net income of approximately $2,929,320. At November 30, 2014, SHGT current assets were $2,976,296 and its current liabilities were $85,233 resulting in a working capital surplus of $2,885,237.
Tampa, Florida – January 14, 2015— Bulova Technologies Group, Inc. (OTC: BTGI) (the “Company”) today announced the formation of Bulova Technologies Advanced Products LLC.
Corporate Progress Report – Moving at Light Speed
FutureWorld Corp. (OTCQB: FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announces the following letter to its shareholders from our Chairman & CEO Sam Talari:
Dear Fellow Shareholders, as the CEO of FutureWorld, I would like to update all of you on our current business progress and upcoming events:
There has been an ever increasing demand for healthy foods and beverages in the market as America’s health awareness continues to grow. Founded in 2008 in Koloa, Hawaii, KonaRed Corporation (OTC: KRED) is making strides to accommodate this recent awareness with healthy beverages and supplements. With their dedicated team, smart marketing strategies and broad distribution, the company seems to be heading down the right road to success.